BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 15,000 shares of the business’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of C$3.82, for a total transaction of C$57,300.00. Following the completion of the sale, the director owned 397,370 shares of the company’s stock, valued at approximately C$1,517,953.40. This represents a 3.64% decrease in their position.
BioRem Price Performance
Shares of BRM opened at C$3.63 on Thursday. The company has a debt-to-equity ratio of 14.17, a quick ratio of 1.08 and a current ratio of 2.04. The company has a 50 day moving average price of C$3.33 and a 200-day moving average price of C$3.01. BioRem Inc. has a fifty-two week low of C$1.87 and a fifty-two week high of C$3.95. The stock has a market capitalization of C$58.93 million, a PE ratio of 10.80 and a beta of 0.81.
BioRem Company Profile
Featured Articles
- Five stocks we like better than BioRem
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
